This SK Hynix Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursdaybenzinga_article·1 day ago, 10:41 AMACTU-1.71%SKHY-0.68%
Actuate Therapeutics Disclosed Failure to Satisfy a Continued Listing Rule or StandardTradingView·Jul 17 at 03:33 PMACTU-1.71%
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga_article·Jul 14 at 12:05 PMGALT-5.88%CARL-2.33%
Top Biotech Gainers: QTTB Sends Strong SIGNAL; AMWL And SI In Focusrttnews·Jul 13 at 09:35 PMAGEN-6.07%SI-2.22%
12 Health Care Stocks Moving In Monday's Intraday Sessionbenzinga_article·Jul 13 at 12:05 PMBIVI+4.55%QTTB-6.00%
Actuate Therapeutics shares are trading higher after the company announced that elraglusib will be evaluated in the BEACON2 clinical trial to identify and advance treatment approaches for children with relapsed and refractory neuroblastoma.benzinga_article·Jun 9 at 02:52 PMACTU-1.71%
Actuate Therapeutics’ Elraglusib Selected for Evaluation in BEACON2 Trial for High-Risk Pediatric Neuroblastoma | ACTU Stock NewsStockTitan·Jun 8 at 10:45 PMACTU-1.71%
Craig-Hallum Remains a Buy on Actuate Therapeutics, Inc. (ACTU)Tip Ranks·May 12 at 08:49 AMACTU-1.71%
Actuate Therapeutics Announces Key Appointment of Industry Veteran to Board of Directors | ACTU Stock NewsStockTitan·May 5 at 11:45 PMACTU-1.71%
